New England Biolabs Continues Microbial Fermentation Partnership with ABEC
4.5.2022 16:28:00 EEST | Business Wire | Press release
ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced it is delivering multiple 40L stainless steel fermenters to New England Biolabs ® (NEB®), further supporting their high-density fermentation of recombinant Escherichia coli and Pichia pastoris. NEB has again selected ABEC based on the recent successful delivery of 400L and 1,000L stainless steel fermenters to their manufacturing facilities in Ipswich and Rowley, MA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220504005176/en/
The 40L fermenters will replicate the larger scale ABEC fermenters in both design and performance, allowing NEB to conduct multidimensional experimental studies to optimize their fermentation processes. NEB, a global supplier-of-choice for scientific researchers, produces over 500 proteins for research and IVD markets. ABEC’s customized approach and ability to deliver high-quality, reliable fermenters are key to supporting NEB in providing advanced proteins to the scientific community while meeting the highest standards of product quality.
“ABEC’s 40L fermenters will allow New England Biolabs to facilitate a seamless transition from development to production,” said Maurice Southworth, Executive Director of Production at New England Biolabs. “ABEC’s ongoing support enables us to increase our fermentation capabilities as we continue to expand our product offerings into new areas of research.”
“We look forward to continuing our fermentation partnership with New England Biolabs,” said Scott Pickering, ABEC CEO and Chairman. “We appreciate their trust and confidence and remain committed to supporting their success.”
About ABEC
Since 1974, ABEC has been a global leader in delivering engineered process solutions and services for manufacturing in the biotech industry. The majority of the world's pharmaceutical and biotech companies are ABEC customers; with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. To learn more about ABEC, visit abec.com, email info@abec.com and follow us on LinkedIn.
About New England Biolabs
Established in the mid 1970’s, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and eight subsidiaries located in Australia, Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com. NEB® and NEW ENGLAND BIOLABS® are registered trademarks of New England Biolabs, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005176/en/
Contact information
Media:
Susan Cooper-Curcio, Director of Marketing, +1 (610) 861 4666, scurcio@abec.com
Deana D. Martin, Ph.D. Associate Director, Marketing Communications, +1 (978) 380-7464, martin@neb.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Measuring Muscles with Quantitative MRI: New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA26.8.2026 15:27:00 EEST | Press release
AMRA Medical is pleased to announce the publication of new research in Neurology demonstrating the potential of quantitative whole-body MRI to measure disease progression in Spinal and Bulbar Muscular Atrophy (SBMA), a rare, progressive neuromuscular disease. The research was also selected for the cover of the issue, providing additional visibility for this important work in neuromuscular disease research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826386576/en/ AMRA Medical - Measuring Muscles with Quantitative MRI The manuscript, titled “Muscle MRI as an imaging biomarker of muscle damage in patients with spinal and bulbar muscular atrophy” highlights how MRI-based muscle composition biomarkers can provide sensitive and objective measures of disease-related change over time. With AMRAⓇ Researcher, the study evaluated 25 participants with SBMA to investigate the ability of fat-referenced MRI to assess changes in musc
KEWPIE IT. London discovers the Mayo behind the Iconic Tamago Sando26.8.2026 15:10:00 EEST | Press release
Kewpie Corporation(TOKYO:2809) is inviting Londoners to discover how one simple squeeze can transform one of the world's most iconic sandwiches. Through a new experiential pop-up in Covent Garden Piazza, the iconic Japanese mayonnaise brand is bringing its rich, creamy, umami flavour to the heart of London's food scene, celebrating the ingredient that elevates the Tamago Sando AKAthe iconic Japanese Egg Sandwich. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826081552/en/ An image of the pop-up scheduled to take place at Covent Garden Piazza in London KEWPIE MAYONNAISE is mostly made with egg yolks (not whole eggs), which is responsible for its richness and umami flavour, alongside their proprietary vinegars. With its signature bottle and unique taste, KEWPIE MAYONNAISE has earned a loyal following among chefs and food lovers for its distinctive richness and depth of flavour. Rather than following food trends, the brand
Copeland Appoints Sandro Matic as President, Americas, and Gwen Cheramy as President, Europe26.8.2026 15:00:00 EEST | Press release
Copeland, a global provider of compression technologies and controls solutions, today announced that Gwen Cheramy will join the company as President of its Europe business on Oct. 1, 2026, and that Sandro Matic will assume the role of President of its Americas business on Sept. 1, 2026. Matic will continue to lead Europe on an interim basis until Cheramy joins Copeland. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826567313/en/ Sandro Matic, President, Americas for Copeland "Sandro and Gwen are both proven leaders with strong track records of delivering results within our industry,” said Ross B. Shuster, CEO of Copeland. "In their new roles, they will be instrumental in providing leadership to our local colleagues, supporting our customers, and advancing Copeland’s strategic priorities across their respective regions while helping execute our global strategy.” Matic joined the business in 2011, initially with Emerson, a
NetApp Named a Leader in the 2026 Gartner® Magic Quadrant™ for Enterprise Storage Platforms26.8.2026 15:00:00 EEST | Press release
NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced it has been recognized by Gartner as a Leader in the 2026 Gartner Magic Quadrant for Enterprise Storage Platforms, continuing to acknowledge NetApp as a Leader in this market from its inaugural edition of this report in 2025. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute. Additionally, the 2026 Gartner Critical Capabilities for Enterprise Storage Platforms report ranks NetApp first in the Hybrid Cloud Storage Use Case and second in the Hybrid Platform Services Use Case. NetApp believes this recognition validates the company’s ability to help customers address their most pressing data challenges while offering more predictable hardware delivery timelines than its competitors. The NetApp Platform is an intelligent, governed foundation that provides zero-copy access to an organization’s data, wherever it resides. It enables
Pure Lithium Announces Unprecedented Cycling Results From Its Advanced Anode™ Lithium Metal Battery Technology26.8.2026 14:00:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, today announced that our Advanced Anode™ battery, technology developed specifically to enable ultra-long cycling, has achieved more than 9,315 cycles. The cells continue to cycle in the Company's laboratory. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826201214/en/ To the Company’s knowledge, no other lithium metal battery in development has achieved such results under equivalent testing conditions. The performance of the Company’s battery, achieved with negligible capacity fade, far exceeds today’s commercial lithium-ion battery cycling requirements across numerous applications, where performance typically ranges from 250 to 2,000 cycles, depending on the application. These results were achieved at 100% depth of discharge, and charge rates of 1C: 1C.1 “The results of Pure Lithium’s cycling performance are disruptive. Cycle life
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom